BIOMAT Database Logo BIOMAT Database Logo

Menopausal hormone therapy and breast cancer risk: All progestogens are not the same. 2021

Irene Lambrinoudaki
National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.

UI MeSH Term Description Entries

Related Publications

Irene Lambrinoudaki
Is breast cancer risk the same for all progestogens?
August 2014, Archives of gynecology and obstetrics,
Irene Lambrinoudaki
Progestogens in menopausal hormone therapy.
June 2015, Przeglad menopauzalny = Menopause review,
Irene Lambrinoudaki
[Menopausal hormone therapy and breast cancer risk].
June 2020, Der Internist,
Irene Lambrinoudaki
Menopausal hormone therapy and breast cancer risk.
December 2021, Best practice & research. Clinical endocrinology & metabolism,
Irene Lambrinoudaki
Underlying Breast Cancer Risk and Menopausal Hormone Therapy.
June 2020, The Journal of clinical endocrinology and metabolism,
Irene Lambrinoudaki
Menopausal Hormone Therapy Formulation and Breast Cancer Risk.
June 2022, Obstetrics and gynecology,
Irene Lambrinoudaki
The Role of Progestogens in Menopausal Hormone Therapy.
December 2021, Clinical obstetrics and gynecology,
Irene Lambrinoudaki
Progestogen in menopausal hormone therapy and breast cancer risk.
April 2024, Obstetrics & gynecology science,
Irene Lambrinoudaki
Menopausal hormone therapy and breast cancer.
July 2014, The Journal of steroid biochemistry and molecular biology,
Irene Lambrinoudaki
Menopausal Hormone Therapy and Breast Cancer.
January 2022, Cancer journal (Sudbury, Mass.),
Copied contents to your clipboard!